September 03, 2023
A structured cleaning procedure is essential to ensure the effective cleaning of equipment.
September 02, 2023
The ACT EU initiative aims to develop the European Union further as a competitive centre for innovative clinical research.
September 02, 2023
There are many promising trials in the pipeline that may bring big news for major therapeutic areas.
September 02, 2023
Audits and inspections both assure that requirements have been fulfilled and whether documented proof is available, says Siegfried Schmitt, vice president, Technical at Parexel.
August 31, 2023
The Centers for Medicare & Medicaid Services (CMS) has announced the first 10 drugs covered under Medicare Part D selected for negotiation.
August 31, 2023
Bristol Myers Squibb’s Reblozyl (luspatercept-aamt) is approved as a first-line treatment for anemia in adults with lower-risk myelodysplastic syndromes.
August 31, 2023
The updated vaccine will be ready to ship following a positive European Commission review.
August 30, 2023
This is the first biosimilar to Tysabri, an injection for adults with multiple sclerosis.
August 25, 2023
Adam Smith, a House of Representatives member representing Washington's 9th congressional district, discusses the state of U.S. healthcare and pharma.
August 24, 2023
The patent grants Alterity 20 years of exclusivity over a new class of iron chaperone drug candidates.